Furazolidone disposition after intravascular and oral dosing in the channel catfish

References

• Abraham R. T., Knapp J. E., Minnigh M. B., Wong L. K., Zemaitis M. A., Alvin J. D. Reductive metabolism of furazolidone by Escherichia coli and rat liver in vitro. Drug Metabolism and Disposition 1984; 12: 732–741
   PubMed Web of Science ®Google Scholar
• Alderman D. J. Fisheries chemotherapy: a review. Recent Advances in Aquaculture, J. F. Muir, R. J. Roberts. Croom Helm, London 1988; Vol. 3: 1–62
   Google Scholar
• Blanchflower W. J., McCracken R. J., Kennedy D. G. Detection of furazolidone in muscle liquid using chromatography/thermospray mass spectrometry. Residues of Veterinary Drugs in Food, N. Haagsma, A. Ruiter, P. B. Czedik‐Eysenberg. University of Utrecht, Utrecht 1993; 201–205
   Google Scholar
• Carignan G., MacIntosh A. I., Sved S. An assay for furazolidone residues by liquid chromatography with electrochemical detection applicable to depletion studies in pigs. Journal of Agricultural and Food Chemistry 1990; 38: 716–720
   Google Scholar
• Hoogenboom L. A. P., van Kammen M., Berghmans M. C. J., Koeman J. H., Kuiper H. A. The use of pig hepatocytes to study the nature of protein‐bound metabolites of furazolidone: a new analytical method for their detection. Food and Chemical Toxicology 1991; 29: 321–328
   PubMed Web of Science ®Google Scholar
• Hoogenboom L. A. P., van Kammen M., Huveneers‐Oorsprong M. B. M., Kuiper H. A. Study on the role of glutathione in the biotransformation and toxicity of furazolidone using pig hepatocytes. Toxicology in Vitro 1992; 6: 227–237
   PubMed Web of Science ®Google Scholar
• Hoogenboom L. A. P., Polman T. H. G. Simultaneous detection of protein bound residues of the nitrofuran drugs furazolidone, furaltadone, nitrofurazone and nitrofurantoin. Residues of Veterinary Drugs in Food, N. Haagsma, A. Ruiter, P. B. Czedik‐Eysenberg. University of Utrecht, Ultrecht 1993; 376–381
   Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Nakabeppu H., Tatsumi K. Metabolism of furazolidone in eels. Chemical and Pharmaceutical Bulletin 1984; 32: 4193–4196
   PubMed Web of Science ®Google Scholar
• Parker R. M., Walker A. M., Hassanali H. T. Species and maturity differences in the pharmacokinetics of furazolidone. Residues of Veterinary Drugs in Food, N. Haagsma, A. Ruiter, P. B. Czedik‐Eysenberg. University of Utrecht, Utrecht 1993; 523–527
   Google Scholar
• Rupp H. S., Munns R. K., Long A. R., Plakas S. M. Simultaneous determination of nitrofurazone, nitrofurantoin, and furazolidone in channel catfish (Ictalurus punctatus) muscle tissue by liquid chromatography. Journal of AOAC International 1994; 77: 344–350
   PubMed Web of Science ®Google Scholar
• Samuelsen O. B., Solheim E., Lunestad B. T. Fate and microbiological effects of furazolidone in a marine aquaculture sediment. The Science of the Total Environment 1991; 108: 275–283
   PubMedGoogle Scholar
• Stehly G. R., Plakas S. M. Pharmacokinetics, tissue distribution, and metabolism of nitrofurantoin in the channel catfish (Ictalurus punctatus). Aquaculture 1993; 113: 1–10
   Google Scholar
• Tatsumi K., Kitamura S., Kato M., Hiraoka K. Metabolism of sodium nifurstyrenate, a veterinary nitrofuran, in animals and fish. Drug Metabolism and Disposition 1992; 20: 226–233
   PubMedGoogle Scholar
• Tatsumi K., Nakabeppu H., Takahashi Y., Kitamura S. Metabolism in vivo of furazolidone: evidence for formation of an open‐chain carboxylic acid and α‐ketoglutaric acid from the nitrofuran in rats. Archives of Biochemistry and Biophysics 1984; 234: 112–116
   PubMed Web of Science ®Google Scholar
• Tatsumi K., Takahashi Y. Metabolic fate of furazolidone in rats. Chemical and Pharmaceutical Bulletin 1982; 30: 3435–3438
   PubMedGoogle Scholar
• Tatsumi K., Ou T., Yamada H., Yoshimura H., Koga H., Horiuchi T. Isolation and identification of the metabolite of N‐(5‐nitro‐2‐furfurylidene)‐3‐amino‐2‐oxazolidone (furazolidone). Journal of Pharmacobio‐Dynamics 1978; 1: 256–261
   Google Scholar
• Tennent D. M., Ray W. H. Metabolism of furazolidone in swine. Proceedings of the Society of Experimental Biology and Medicine 1971; 138: 808–810
   PubMed Web of Science ®Google Scholar
• Vroomen L. H. M., Berghmans M. C. J., Groten J. P., Koeman J. H., van Bladeren P. J. Reversible interaction of a reactive intermediate derived from furazolidone with glutathione and protein. Toxicology and Applied Pharmacology 1988; 95: 53–60
   PubMed Web of Science ®Google Scholar
• Vroomen L. H. M., Berghmans M. C. J., Hekman P., Hoogenboom L. A. P., Kuiper H. A. The elimination of furazolidone and its open‐chain cyano‐derivative from adult swine. Xenobiotica 1987a; 17: 1427–1435
   PubMed Web of Science ®Google Scholar
• Vroomen L. H. M., Groten J. P., van Muiswinkel K., van Velduizen A., van Bladeren P. J. Identification of a reactive intermediate of furazolidone formed by swine liver microsomes. Chemico‐Biological Interactions 1987b; 64: 167–179
   PubMed Web of Science ®Google Scholar
• Vroomen L. H. M., Berghmans M. C. J., van Bladeren P. J., Groten J. P., Wissink C. J., Kuiper H. A. In vivo and in vitro metabolic studies of furazolidone: a risk evaluation. Drug Metabolism Reviews 1990; 22: 663–676
   PubMed Web of Science ®Google Scholar
• Vroomen L. H. M., Berghmans M. C. J., van Leeuwen P., van DER Struijs T. D. B., de Vries P. H. U., Kuiper H. A. Kinetics of 14C‐furazolidone in piglets upon oral administration during 10 days and its interaction with tissue macro‐molecules. Food Additives and Contaminants 1986; 3: 331–346
   Web of Science ®Google Scholar
• Wolwer‐Rieck U., Buning‐Pfaue H. The residue behaviour of the furazolidone metabolite 3‐(4‐cyano‐2‐oxobutylideneamino)‐2‐oxazolidone in trout. Zeitschrift für Lebensmittel‐Untersuchung und‐Forschung 1990; 191: 319–321
   PubMedGoogle Scholar